Member Info for PL75

I agree, I think we’ve had enough puns. I’m kale-ing it a day

All thanks to Victory12 for the thread about the share price being stable

All thanks to the golden cross

Btw, I know you knew that answer Bein, there just wasn’t a hope of that twat answering honestly.

Bein, I’ll answer. The reason eggy is longer on twatter is the same reason that NDN departed from here. The alias was completely shot, it reached the stage they only got ridicule in reply. The problem with twatter for gormless moronic trolls like him is that they’re easily blocked. They get no attention and that’s what weirdo’s enjoy. The cover of the amiable chap full of the positive joys of spring that initially joined has been utterly blown. Everyone now knows that it’s the same oddball behind these accounts as he can’t suppress his odious personality despite his best efforts. Plus he said he was NDN when he cried about it, that gave it away. This reincarnation will disappear and another will replace it.

Toaster learnt from the best so he know what selling means for the share price. He loves crayons and blindfolds. I’m expecting him to start mentioning the ascending triangle soon, but first things first we’re in line for a golden cross after surviving the death spiral cross.

That’s a shame, a week before the 21st

Ideaya’s share price is at the same level 25p ish today as it was on the day that PR was shared.

"That's why you have clinical trials with hundreds of patients."

Nice one Stato.

Cba. You’re too thick.

Thanks for sharing your perfectly valid and positive idea VS.

The idiot still doesn’t understand it’s a platform. Fab.

Not his only hobby

You’d probably not waste your time on stupid irrelevant nonsense. Twat.

Plus it’s only 1%. Great stat Stato. So, reduce the TAM of billions a bit and we’ll be ok. Certainly not worth him worrying his grubby little pea brain. He can get back to harassing nurses.

‘Was the cohort big enough to adequately cover the affects of AVA6000 on patients that have Rheumatoid or do you think a few more patients might be sensible before reaching a conclusion on that one?’

You tell me Stato. Clearly Alan and the safety committee don’t care. Perhaps you should STFU and leave it to them rather than inventing problems.

Several of the participants on the trial will have arthritis. The median age of some of the cohorts is 63. Eggy is just being eggy, racking his pea brain to come up with a negative twist to a positive post regarding a share he’s not invested in. He’s a twat.

Meanwhile the safety committee have declared it safe, we’re in the final cohort of the phase to examine safety. Fact.

The best news is that you’re not in charge. Who should we pick to test the safety of our potentially lethal drug? Errr dunno, shall we pick these patients with slightly sore knuckles that are otherwise healthy? Yeah, great idea, best test out our toxin on patients that prefer their knitting to their hearts.

Yes, that’s what happens in safety trials eggy. Stick to hassling nurses, you grubby fool.

Right, then perhaps you shouldn’t post a load of rollocks about the number of patients required then.

Oh, so phase 1a, designed to assess the safety isn’t adequate to assess safety and the safety committee compromising experts in safety who have been advising increases in doses are wrong. Oops, best let Alan know, he’s going to make a right tit of himself with the FDA.

And I’ve sarcastically dealt with your pointless nonsense by describing someone incapable of playing frere jacques on the piano being an AE on the trial.

Any answers to my Qs? I’d love to hear the details behind your post.

‘That's fine to monitor the lack of common adverse reactions and side effects which is important but it's the left field unexpected issues that need hundreds of patients (or more) to completely exclude significant rare and idiosyncratic problems. ‘

Can you explain the stats behind that? Can you also detail what considerations will be made by the regulator for the idiosyncratic problems you’re busy dreaming up?